| CHDD | Home | Site Map | Search | Directory | Admin Services | |
|||||||
| |
Center on Human Development and Disability | ||||||||
| About CHDD | IDDRC | UCEDD |
| Collaborative |
Dr. Andrews the genetics of hematopoietic (blood-generating) stem cells. Currently, he researches factors that affect interactions of transplanted (allogeneic) CD34+ hematopoietic stem cells with progenitor cells. Hematopoietic stem cells generate all types of blood cells while progenitor cells are precursors of more specific types. His research may contribute to in-utero therapies for disorders that can cause developmental disabilities. For example, if transplanted CD34+ hematopoietic cells can be engrafted with progenitor cells in utero, they may be effective in treating leukodystrophies, rare degenerative brain disorders caused by defects in the growth or development of the myelin sheaths that insulate nerve fibers. Robert Andrews's Seattle Cancer Care Alliance web page
University of Washington • Center on Human Development and Disability Box 357920 • Seattle WA 98195-7920 USA • 206-543-7701 •chdd@uw.edu Copyright © 1996—2013 Center on Human Development and Disability. Updated: November 16, 2011 |
|||